Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -2.84% | -3.18% | -53.56% |
May. 09 | BioXcel Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | Transcript : BioXcel Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.56% | 51.42M | |
+18.15% | 124B | |
+18.02% | 112B | |
+3.70% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-16.31% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- BTAI Stock
- News BioXcel Therapeutics, Inc.
- Guggenheim Adjusts Price Target on BioXcel Therapeutics to $46 From $50, Maintains Buy Rating